Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Potential Anti-inflammatory Effect of Roflumilast as Add-on Therapy in The Management of Hospitalized Patients With Mild Acute Respiratory Distress Syndrome

NCT04744090 is registered in ClinicalTrials.gov with Cairo University as lead sponsor.

NCT NCT04744090
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04744090 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Potential Anti-inflammatory Effect of Roflumilast as Add-on Therapy in The Management of Hospitalized Patients With Mild Acute Respiratory Distress Syndrome
Lead sponsor
Cairo University
Phase
Phase 2
Overall status
Completed
Start date
March 21, 2021
Completion date
January 1, 2022
Enrollment
76 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

respiratory distress syndrome, adult